Teva launches cash and shares bid for Mylan
Teva Pharmaceuticals has announced a cash and shares bid for US rival Mylan at $82 per share.
Mylan Inc.
$0.00
19:30 08/12/22
0.00%
$0.00
Nasdaq 100
19,800.74
12:15 07/10/24
-1.17%
-234.28
--More to follow--